首页> 中文期刊> 《世界临床病例杂志》 >PNPLA3 rs139051 is associated with phospholipid metabolite profile and hepatic inflammation in nonalcoholic fatty liver disease

PNPLA3 rs139051 is associated with phospholipid metabolite profile and hepatic inflammation in nonalcoholic fatty liver disease

         

摘要

AIM To investigate the effect of PNPLA3 polymorphisms on serum lipidomics and pathological characteristics in nonalcoholic fatty liver disease(NAFLD).METHODS Thirty-four biopsy-proven NAFLD patients from Northern,Central,and Southern China were subjected to stratification by genotyping their single nucleotide polymorphisms(SNPs)in PNPLA3.Ultra performance liquid chromatography?tandem mass spectrometry was then employed to characterize the effects of PNPLA3 SNPs on serum lipidomics.In succession,correlation analysis revealed the association of PNPLA3-related lipid profile and hepatic pathological characteristics on a basis of steatosis,activity,and fibrosis assessment.The variant-based scoring of hepatocyte steatosis,ballooning,lobular inflammation,and liver fibrosis was finally performed so as to uncover the actions of lipidomics-affecting PNPLA3 SNPs in NAFLD-specific pathological alterations.RESULTS PNPLA3 SNPs(rs139051,rs738408,rs738409,rs 2072906,rs2294918,rs2294919,and rs4823173)demonstrated extensive association with the serum lipidomics,especially phospholipid metabolites[lysophosphatidylcholine(LPC),lysophosphatidylcholine plasmalogen(LPCO),lysophosphatdylethanolamine(LPE),phosphatidylcholine(PC),choline plasmalogen(PCO),phosphatidylethanolamine(PE),ethanolamine plasmalogen(PEO)],of NAFLD patients.PNPLA3 rs139051(A/A genotype)and rs2294918(G/G genotype)dominated the up-regulatory effect on phospholipids of LPCs(LPC 17:0,LPC 18:0,LPC 20:0,LPC 20:1,LPC 20:2)and LPCOs(LPC O-16:1,LPC O-18:1).Moreover,subjects with high-level LPCs/LPCOs were predisposed to low-grade lobular inflammation of NAFLD(rho:-0.407 to-0.585,P<0.05-0.001).The significant correlation of PNPLA3 rs139051 and inflammation grading[A/A vs A/G+G/G:0.50(0.00,1.75)vs 1.50(1.00,2.00),P<0.05]further demonstrated its pathological role based on the modulation of phospholipid metabolite profile.CONCLUSION The A/A genotype at PNPLA3 rs139051 exerts an upregulatory effect on serum phospholipids of LPCs and LPCOs,which are associated with low-grade lobular inflammation of NAFLD.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号